Safeguard Scientifics Announces First Quarter 2012 Financial Results

Safeguard Scientifics, Inc. , a holding company that builds value in growth-stage life sciences and technology companies, today announced that its consolidated net loss for the three months ended March 31, 2012 was $9.7 million, or $0.46 per share, compared with net loss of $9.0 million, or $0.44 per share, for the same period in 2011.

Press Release

Safeguard Scientifics Inc. Posted on:26 Apr 12 Safeguard Scientifics, Inc. (NYSE: SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that its consolidated net loss for the three months ended March 31, 2012 was $9.7 million, or $0.46 per share, compared with net loss of $9.0 million, or $0.44 per share, for the same period in 2011 ...

Safeguard Scientifics Announces First Quarter 2012 Financial Results - MarketWatch (press release)

Safeguard Scientifics Announces First Quarter 2012 Financial Results MarketWatch (press release) After 510(k) clearance and CLIA waiver, the BD Veritor(TM) System was launched in the US market in December 2011 with a test for influenza. Approval in Japan was received in January 2012 for influenza and strep A, and sales commenced in March 2012. and more »

NYC Health and Hospitals Corporation v. NYS Commission of Correction, No. 64 - New York Law Journal (registration)

NYC Health and Hospitals Corporation v. NYS Commission of Correction, No. 64 New York Law Journal (registration) Supreme Court agreed with HHC to the extent of holding in separate decisions that HIPAA permitted, but did not require, HHC's surrender of the sought records absent authorization from Mr. Frazier's personal representative, and that the records were ...